Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)
Sponsor
University Hospital, Brest (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05986825
Collaborator
(none)
60
1
12
5
Study Details
Study Description
Brief Summary
Validation of the French Version of the Score on Quality of Life in Hidradenitis Suppurativa. The French HiSQOL will be completed by 60 patients with hidradenitis suppurativa a first time, and a second time 1 week later.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
60 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)
Anticipated Study Start Date
:
Sep 1, 2023
Anticipated Primary Completion Date
:
Sep 1, 2024
Anticipated Study Completion Date
:
Sep 1, 2024
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental Patients with Verneuil disease |
Other: Verneuil questionnaire Validation
Request patient to Complete the questionnaire for validation of the French version
|
Outcome Measures
Primary Outcome Measures
- Validation of the questionnaire [During the visit and 1 week later]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Age ≥18 years
-
Patient with Verneuil disease
-
Beneficiary of or affiliated to a social security insurance
-
Participation agreement
Exclusion Criteria:
-
Patients physically or mentally unable to complete questionnaires.
-
Refusal to participate
-
Patient under legal protection (guardianship, curatorship) or deprived of liberty
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU Brest | Brest | France | 29200 |
Sponsors and Collaborators
- University Hospital, Brest
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT05986825
Other Study ID Numbers:
- 29BRC22.0225 (QUALIVER)
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 14, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: